All News #Library
Biotech
Stapokibart Approved In China For Moderate-To-Severe Atopic Dermatitis
12 Sep 2024 //
PR NEWSWIRE
China NMPA Approves PADCEV For Advanced Urothelial Cancer
19 Aug 2024 //
PR NEWSWIRE

Market Place
Sourcing Support